Spivak, J. L., & Moliterno, A. R. (2021). The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN. Front Oncol.
Citação norma ChicagoSpivak, Jerry L., and Alison R. Moliterno. "The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN." Front Oncol 2021.
MLA CitationSpivak, Jerry L., and Alison R. Moliterno. "The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN." Front Oncol 2021.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.